Citations

Clear

3138 citation(s) found for "Smith, AM".

Evaluation of Calcium Alginate-tipped Aluminum Swabs Transported in Culturettes® Containing Ampules of 2-Sucrose Phosphate Medium for Recovery of Chlamydia trachomatis
Smith, Thomas F., Weed, Lyle A.

Mayo Clinic

American Journal of Clinical Pathology | March 18, 2016 | Volume: 80 | Issue: 2 | Pages: 213-215

10.1093/ajcp/80.2.213 | PMID 6349325 Get It

Detection of Chlamydial Cervicitis by Papanicolaou Stained Smears and Culture
Dorman, Sandy A., Danos, Leigh M., Wilson, Debbie J., Noller, Kenneth L., Malkasian, George D., Goellner, John R., Smith, Thomas F., Lm, Danos

Mayo Clinic

American Journal of Clinical Pathology | March 18, 2016 | Volume: 79 | Issue: 4 | Pages: 421-425

10.1093/ajcp/79.4.421 | PMID 6837510 Get It

Prevalence of Antibody to Chlamydia in Renal Transplant Recipients and Other Population Groups
Smith, Thomas F., Scoy, Robert E. Van, Taswell, Howard F., Wilson, Deborah J.

Mayo Clinic

American Journal of Clinical Pathology | March 18, 2016 | Volume: 78 | Issue: 2 | Pages: 228-231

10.1093/ajcp/78.2.228 | PMID 7048942 Get It

Comparison of Growth of Mycoplasma Pneumoniae on Modified New York City and Hayflick Media
Dorman, Sandy A., Smith, Thomas F., Wilson, Deborah J.

Mayo Clinic

American Journal of Clinical Pathology | March 18, 2016 | Volume: 79 | Issue: 2 | Pages: 235-237

10.1093/ajcp/79.2.235 | PMID 6401916 Get It

H. P. Smith Award Lecture: H. P. Smith’s Place in the History of Blood Coagulation
Owen, Charles A.

Mayo Clinic

American Journal of Clinical Pathology | March 18, 2016 | Volume: 81 | Issue: 4 | Pages: 424-426

10.1093/ajcp/81.4.424 | PMID 6367422 Get It

Detection of Viral and Chlamydial Antigens in Open-Lung Biopsy Specimens
Gleaves, Curt A., Smith, Thomas F., Wold, Arlo D., Wilson, Walter R.

Mayo Clinic

American Journal of Clinical Pathology | March 18, 2016 | Volume: 83 | Issue: 3 | Pages: 371-374

10.1093/ajcp/83.3.371 | PMID 2983526 Get It

Evaluation of Cytomegelisa™ Immunoglobulin M Assay and Comparison with Indirect Fluorescent Antibody Testing of QAE-Sephadex® A50-Treated Sera
Elder, B. Laurel, Smith, Thomas F.

Mayo Clinic

American Journal of Clinical Pathology | March 17, 2016 | Volume: 87 | Issue: 2 | Pages: 230-235

10.1093/ajcp/87.2.230 | PMID 2433937 Get It

The Effect of Centrifugation on the Rapid Detection of Adenovirus in Shell Vials
Espy, Mark J., Hierholzer, John C., Smith, Thomas F.

Mayo Clinic

American Journal of Clinical Pathology | March 17, 2016 | Volume: 88 | Issue: 3 | Pages: 358-360

10.1093/ajcp/88.3.358 | PMID 3307377 Get It

Non-Hodgkin's Lymphomas of the Gastrointestinal Tract: An Evaluation of Paraffin Section Immunostaining
Wolf, Barbara C., Martin, Alvin W., Ree, H. J., Banks, Peter M. , Smith, Susie I., Neiman, Richard S.

Mayo Clinic

American Journal of Clinical Pathology | March 17, 2016 | Volume: 93 | Issue: 2 | Pages: 233-239

10.1093/ajcp/93.2.233 | PMID 1689097 Get It

Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms
Pratz, Keith W. , Koh, Brian D. , Patel, Anand G. , Flatten, Karen S., Poh, Weijie , Herman, James G. , Dilley, Robert L. , Harrell, Maria I., Karp, Judith E. , Swisher, Elizabeth M. , McDevitt, Michael A. , Kaufmann, Scott H. , Smith, B. Douglas , Swisher, Elizabeth M , Poh, Weijie

Mayo Clinic

Clinical Cancer Research | March 15, 2016 | Volume: 22 | Issue: 15 | Pages: 3894-3902

10.1158/1078-0432.ccr-15-2351 | PMID 26979391 Get It

Abstract Purpose: DNA repair defects have been previously reported in myeloproliferative neoplasms (MPN). Inhibitors of PARP have shown activity in solid tumors with defects in homologous recombination (HR). This study was performed to assess MPN sensitivity to PARP inhibitors ex vivo. Experimental Design: HR pathway integrity in circulating myeloid cells was evaluated by assessing the formation of RAD51 foci after treatment with ionizing radiation or PARP inhibitors. Sensitivity of MPN erythroid and myeloid progenitors to PARP inhibitors was evaluated using colony formation assays. Results: Six of 14 MPN primary samples had reduced formation of RAD51 foci after exposure to ionizing radiation, suggesting impaired HR. This phenotype was not associated with a specific MPN subtype, JAK2 mutation status, or karyotype. MPN samples showed increased sensitivity to the PARP inhibitors veliparib and olaparib compared with normal myeloid progenitors. This hypersensitivity, which was most pronounced in samples deficient in DNA damage–induced RAD51 foci, was observed predominantly in samples from patients with diagnoses of chronic myelogenous leukemia, chronic myelomonocytic leukemia, or unspecified myelodysplastic/MPN overlap syndromes. Conclusions: Like other neoplasms with HR defects, MPNs exhibit PARP inhibitor hypersensitivity compared with normal marrow. These results suggest that further preclinical and possibly clinical study of PARP inhibitors in MPNs is warranted. Clin Cancer Res; 22(15); 3894–902. ©2016 AACR.